BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 26686425)

  • 1. Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.
    Au JL; Yeung BZ; Wientjes MG; Lu Z; Wientjes MG
    Adv Drug Deliv Rev; 2016 Feb; 97():280-301. PubMed ID: 26686425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma.
    Liu Y; Zhou J; Li Q; Li L; Jia Y; Geng F; Zhou J; Yin T
    Adv Drug Deliv Rev; 2021 May; 172():80-103. PubMed ID: 33705874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery and transport to solid tumors.
    Jang SH; Wientjes MG; Lu D; Au JL
    Pharm Res; 2003 Sep; 20(9):1337-50. PubMed ID: 14567626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
    Jia M; Zhang D; Zhang C; Li C
    J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
    Chen Q; Liu G; Liu S; Su H; Wang Y; Li J; Luo C
    Trends Pharmacol Sci; 2018 Jan; 39(1):59-74. PubMed ID: 29153879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics.
    Steichen SD; Caldorera-Moore M; Peppas NA
    Eur J Pharm Sci; 2013 Feb; 48(3):416-27. PubMed ID: 23262059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle mediated cancer immunotherapy.
    Gupta J; Safdari HA; Hoque M
    Semin Cancer Biol; 2021 Feb; 69():307-324. PubMed ID: 32259643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering extracellular matrix to improve drug delivery for cancer therapy.
    He X; Yang Y; Li L; Zhang P; Guo H; Liu N; Yang X; Xu F
    Drug Discov Today; 2020 Sep; 25(9):1727-1734. PubMed ID: 32629171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
    Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
    Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.
    Stylianopoulos T; Munn LL; Jain RK
    Trends Cancer; 2018 Apr; 4(4):292-319. PubMed ID: 29606314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment.
    Kanapathipillai M; Brock A; Ingber DE
    Adv Drug Deliv Rev; 2014 Dec; 79-80():107-18. PubMed ID: 24819216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.
    Kirtane AR; Kalscheuer SM; Panyam J
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1731-47. PubMed ID: 24036273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to drug delivery in interventional oncology.
    Sheth RA; Hesketh R; Kong DS; Wicky S; Oklu R
    J Vasc Interv Radiol; 2013 Aug; 24(8):1201-7. PubMed ID: 23735316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrostatic driven transport enhances penetration of positively charged peptide surfaces through tumor extracellular matrix.
    Mohanty RP; Liu X; Ghosh D
    Acta Biomater; 2020 Sep; 113():240-251. PubMed ID: 32428687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Microenvironment-Enabled Nanotherapy.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2018 Apr; 7(8):e1701156. PubMed ID: 29283221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-assisted strategies provide new perspectives to improve the nanoparticle delivery to tumor.
    Zhang D; He J; Zhou M
    Adv Drug Deliv Rev; 2023 Feb; 193():114642. PubMed ID: 36529190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy.
    Tang L; Mei Y; Shen Y; He S; Xiao Q; Yin Y; Xu Y; Shao J; Wang W; Cai Z
    Int J Nanomedicine; 2021; 16():5811-5829. PubMed ID: 34471353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment.
    Niland S; Eble JA
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.